BioReference broadens CV test access:
This article was originally published in Clinica
LipoScience has provided BioReference Laboratories with access to its NMR LipoProfile test, so that the latter can use the technology in its new Advanced Cardiovascular Testing (ACT) programme. ACT is aimed at providing comprehensive cardiovascular reports, and will utilise the LipoProfile, which uses NMR spectroscopy to analyse blood plasma samples and inform doctors on the amount of low-density lipoprotein (LDL) particles present. LDL particles transport cholesterol from the liver, and are an indicator of potential heart disease and atherosclerosis levels. This collaboration is in line with LipoScience's goal of broadening the access of the LipoProfile test.